e-ISSN: XXXX-XXXX  · Published by Leo Marcom Private Limited, Hyderabad, India

An open-access publication of World Pharma Today

World Pharma Today

Peer-reviewed · Open access

Content Management / Subject Areas

Subject Areas

World Pharma Today Journal publishes across 13 subject domains and 98 topics. At submission you nominate one primary topic and up to two secondary topics; the primary topic determines which handling editor takes the manuscript.

Total Subjects

13

Total Topics

98

Article Classification

Primary + Secondary

  1. 1. Target identification and validation
  2. 2. Medicinal and pharmaceutical chemistry
  3. 3. High-throughput and phenotypic screening
  4. 4. Structure-based and computer-aided drug design
  5. 5. Lead optimisation and structure–activity relationships
  6. 6. Natural products and phytopharmaceuticals
  7. 7. Peptide, oligonucleotide and macrocyclic therapeutics
02 Pharmacology 8 Topics
  1. 1. Molecular and cellular pharmacology
  2. 2. Pharmacodynamics and receptor pharmacology
  3. 3. Neuropharmacology and CNS drug action
  4. 4. Cardiovascular and metabolic pharmacology
  5. 5. Immunopharmacology and inflammation
  6. 6. Oncology pharmacology and chemotherapy
  7. 7. Antimicrobial, antiviral and antiparasitic pharmacology
  8. 8. Veterinary pharmacology
  1. 1. Absorption, distribution, metabolism and excretion
  2. 2. Drug metabolism and cytochrome P450 enzymology
  3. 3. Bioavailability and bioequivalence
  4. 4. Population PK/PD modelling and simulation
  5. 5. Physiologically based pharmacokinetic (PBPK) modelling
  6. 6. Drug–drug, drug–food and herb–drug interactions
  7. 7. Therapeutic drug monitoring
  1. 1. Preclinical and regulatory toxicology
  2. 2. Genotoxicity, carcinogenicity and reproductive toxicology
  3. 3. Organ toxicity
  4. 4. In vitro models, new approach methodologies and the 3Rs
  5. 5. Clinical and forensic toxicology
  6. 6. Impurities, nitrosamines, extractables and leachables
  7. 7. Occupational exposure limits and containment
  1. 1. In vivo disease models and target engagement
  2. 2. Organ-on-chip, organoids and 3D culture systems
  3. 3. In vivo efficacy and proof-of-concept studies
  4. 4. Translational imaging and non-invasive readouts
  5. 5. Biomarkers and companion diagnostics
  6. 6. Translational study design and first-in-human transition
  7. 7. Reverse translation and bedside-to-bench research
  8. 8. Drug repurposing and repositioning
  9. 9. Reproducibility and preclinical study quality
  1. 1. Phase I to Phase IV trial design and conduct
  2. 2. Adaptive, platform, basket and umbrella trials
  3. 3. Decentralised and hybrid trials
  4. 4. Real-world evidence and observational research
  5. 5. Biostatistics, endpoints and clinical data management
  6. 6. Recruitment, retention and diversity in trial populations
  7. 7. Good Clinical Practice, site management and monitoring
  8. 8. Bioethics and informed consent
  1. 1. Preformulation and solid-state characterisation
  2. 2. Oral solid dosage form development
  3. 3. Parenteral, ophthalmic and sterile product formulation
  4. 4. Nanomedicine, liposomes and lipid nanoparticles
  5. 5. Controlled, modified and targeted release
  6. 6. Transdermal, inhalation, nasal and mucosal delivery
  7. 7. Paediatric, geriatric and patient-centric formulation
  8. 8. Excipient science and compatibility
  9. 9. Lyophilisation and freeze-drying
  1. 1. Monoclonal antibodies and antibody–drug conjugates
  2. 2. Recombinant proteins, enzymes and hormones
  3. 3. Vaccines, adjuvants and platforms
  4. 4. Cell and gene therapy including CAR-T, AAV and CRISPR
  5. 5. mRNA and nucleic-acid therapeutics
  6. 6. Biosimilar development, comparability and interchangeability
  7. 7. Upstream and downstream bioprocessing
  8. 8. Analytical characterisation of biologics and immunogenicity
  1. 1. Process development, scale-up and technology transfer
  2. 2. Continuous manufacturing and process analytical technology
  3. 3. Aseptic processing, sterilisation and containment
  4. 4. Quality by Design and process validation
  5. 5. GMP compliance, auditing and data integrity
  6. 6. Analytical method development and validation
  7. 7. Stability testing and shelf-life prediction
  8. 8. Cleaning validation and contamination control
  9. 9. Facility design, utilities and single-use systems
  1. 1. Regulatory affairs, CTD dossiers and submissions
  2. 2. Global harmonisation across ICH, WHO, FDA, EMA, CDSCO and PMDA
  3. 3. Pharmacovigilance, signal detection and risk management
  4. 4. Post-marketing surveillance and risk-management plans
  5. 5. Pharmaceutical law, intellectual property and patent strategy
  6. 6. Medical devices and drug–device combination products
  1. 1. Clinical pharmacy and medication therapy management
  2. 2. Pharmacoeconomics and health technology assessment
  3. 3. Adherence, medication safety and patient outcomes
  4. 4. Market access, pricing and reimbursement
  5. 5. Antimicrobial stewardship and resistance
  6. 6. Pharmacogenomics and precision medicine
  7. 7. Pharmacy education and workforce development
  1. 1. Artificial intelligence and machine learning in drug discovery
  2. 2. Digital health, telemedicine and connected devices
  3. 3. Bioinformatics, cheminformatics and multi-omics
  4. 4. Pharmaceutical supply chain, logistics and cold chain
  5. 5. Serialisation, traceability and anti-counterfeiting
  6. 6. Packaging, labelling and device human factors
  7. 7. Computer system validation and Pharma 4.0
  1. 1. Green chemistry and sustainable manufacturing
  2. 2. Pharmaceuticals in the environment
  3. 3. Access to medicines and manufacturing in low- and middle-income countries
  4. 4. Global health, immunisation and outbreak response
  5. 5. Nutraceuticals, cosmeceuticals and OTC products
  6. 6. Traditional, herbal and Ayurvedic medicine standardisation

How subjects work

Choosing your topics at submission

  1. 1 Nominate one primary topic and up to two secondary topics from the 98 numbered topics.
  2. 2 The primary topic determines which handling editor takes the manuscript.
  3. 3 Work outside these 13 domains is returned quickly, so you can submit elsewhere without losing time.
  4. 4 Negative, confirmatory and methodological studies are considered where the study design is sound.

World Pharma Today Journal · Subject & Topic Management

Translate »